Latest Articles
- ArticleTargeted RNA Sequencing of VZV-Infected Brain Vascular Adventitial Fibroblasts Indicates That Amyloid May Be Involved in VZV VasculopathyAndrew N. Bubak, Christina N. Como, James E. Hassell, et al.November 10, 2021
- ArticleCOVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisFarren Basil Shaw Briggs, Farrah J. Mateen, Hollie Schmidt, et al.November 09, 2021
- ArticleCOVID-19 Severity in Multiple SclerosisPutting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.November 09, 2021
- ArticleCCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' TreatmentsRaphael Bernard-Valnet, Xavier Moisset, Nicolas Maubeuge, et al.November 02, 2021
- ArticleClinical and Laboratory Features in Anti-NF155 Autoimmune NodopathyLorena Martín-Aguilar, Cinta Lleixà, Elba Pascual-Goñi, et al.November 02, 2021
- ArticleGRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated DisorderFumitaka Shimizu, Ryo Ogawa, Yoichi Mizukami, et al.November 01, 2021
- ArticleMyelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSFClinical Implication of Testing and Association With DisabilityYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.October 28, 2021
- ArticleCSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune EncephalitisMarc Dürr, Gunnar Nissen, Kurt-Wolfram Sühs, et al.October 25, 2021
- ArticleNew BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSDYukio Takeshita, Susumu Fujikawa, Kenichi Serizawa, et al.October 19, 2021
- ArticleEvaluation of Age-Dependent Immune Signatures in Patients With Multiple SclerosisMelanie Eschborn, Marc Pawlitzki, Timo Wirth, et al.October 19, 2021
Pages
Advertisement